Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Assets: 2022-2024

Historic Assets for Gossamer Bio (GOSS) over the last 3 years, with Dec 2024 value amounting to $315.3 million.

  • Gossamer Bio's Assets fell 40.49% to $208.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $208.8 million, marking a year-over-year decrease of 40.49%. This contributed to the annual value of $315.3 million for FY2024, which is 1.08% up from last year.
  • According to the latest figures from FY2024, Gossamer Bio's Assets is $315.3 million, which was up 1.08% from $311.9 million recorded in FY2023.
  • Gossamer Bio's Assets' 5-year high stood at $315.3 million during FY2024, with a 5-year trough of $272.4 million in FY2022.
  • In the last 3 years, Gossamer Bio's Assets had a median value of $311.9 million in 2023 and averaged $299.9 million.
  • Data for Gossamer Bio's Assets shows a peak YoY rose of 14.49% (in 2023) over the last 5 years.
  • Over the past 3 years, Gossamer Bio's Assets (Yearly) stood at $272.4 million in 2022, then grew by 14.49% to $311.9 million in 2023, then grew by 1.08% to $315.3 million in 2024.